News
Most Read

Apollomics begins dosing in Phase I AML treatment trial in China
Dicerna and Roche start Phase II trial of GalXC RNAi candidate in hepatitis B
Marker Therapeutics treats first subject in acute myeloid leukaemia trial

Most Recent

Clinical Trials

Apollomics begins dosing in Phase I AML treatment trial in China

05 Mar 2021
Analysis
Sections

Features
Comment
Projects
Most Read

OCT West Coast: the post-pandemic outlook for clinical trials
OCT West Coast: Covid-19’s impact on clinical trials
OCT West Coast: key points on engaging patients and advocacy groups

Most Recent

Clinical Trials

OCT West Coast: the post-pandemic outlook for clinical trials

03 Mar 2021
Sectors
Sections

Clinical Trials
Approvals
Clinical Research
Operations
Outsourcing
Supply Chain
Cold Chain
Data Management
Medical Devices
Most Read

Immuno-oncology high prescriber survey reveals which R&D strategies the industry should focus on
Apollomics begins dosing in Phase I AML treatment trial in China
Dicerna and Roche start Phase II trial of GalXC RNAi candidate in hepatitis B

Most Recent

Clinical Research

Immuno-oncology high prescriber survey reveals which R&D strategies the industry should focus on

05 Mar 2021
Themes
Deals
Most Read

Altasciences completes acquisition of US-based CRO WCCT Global
Investment firm GI Partners closes Clinical Ink acquisition
Investment firm GI Partners to acquire minority interest in Clinical Ink

Most Recent

Clinical Trials

Altasciences completes acquisition of US-based CRO WCCT Global

19 Feb 2021
Companies
Sections

Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Most Read

Kolabtree
VaLea Clinical Trials
Linari NanoTech

Most Recent

Clinical Trials

Kolabtree

24 Feb 2021
Magazine
Events

Menu

News
Analysis
Investment
Sectors
Deals
Tech
Disruption
Coronavirus

Partners

Accelerating Clinical Trials
Simplifying Clinical Trials

Tools

Companies
Awards
Events
Magazine

The Company

About Us
Contact Us
Advertise With Us
Visit GlobalData

Login
Register

Login
Register

Approval of Roche’s Tecentriq could mark turning point in frontline therapy for Advanced Bladder Cancer

Powered by

About Us
Editorial Approach
Contact Us
Terms and Conditions
Privacy Policy

© Copyright 2021 Verdict Media Limited.

Lost Password Back ⟶
Login
Register

Lost Password?

Registration is disabled.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Continue Learn more